Wird geladen...
Selective serotonin reuptake inhibitors and Alzheimer’s disease
Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are being prioritized. While the debate regarding whether depression is an etiological risk factor or a prodrome of AD rages on, a key determini...
Gespeichert in:
| Veröffentlicht in: | Neural Regen Res |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer - Medknow
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862425/ https://ncbi.nlm.nih.gov/pubmed/31535641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.264445 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|